Is the price fair?
What MGTX's price assumes
MeiraGTx Holdings plc did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 8.83× revenue.
8.83
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 0.40%
Free cash flow yield · Biotechnology median 2.5%
- Growth the price implies
- +41%
Growth the price implies · What free cash flow would have to do every year for a decade to justify today's price, discounted at 9.0%.
Details›
- EV / EBIToperating margin −132%: the multiple describes the denominator
- not meaningful
- Free cash flow, trailing twelve months
- $4.2M
- Market capitalisation
- $1.05B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.